Wegovy is now available in both pill and injectable forms, offering more flexibility for weight-loss treatment
Trial participants experienced different levels of % total body weight loss depending on the dose: Percentage of total body weight loss on retatrutide After 48 weeks , 83% of patients taking 12 mg lost at least 15% of their body weight , compared to just 2% of those who were on a placebo
Synergy means the combination exceeds what an additivity model predicts
Unlike human GLP-1, the long half-life of semaglutide (about 1 week) allows it to be administered subcutaneously once a week
These medications enhance insulin secretion in response to meals, which can affect energy availability during exercise
The drug lost its patent exclusivity in India in late March, triggering a host of generic, or copycat, versions of the drug, launched at cheaper (50-90% lower) costs